253 related articles for article (PubMed ID: 19899725)
1. [Will the therapy of chronic heart failure be guided by plasma levels of natriuretic peptides?].
Hradec J; Krupicka J; Janota T
Cas Lek Cesk; 2009; 148(8):383-8. PubMed ID: 19899725
[TBL] [Abstract][Full Text] [Related]
2. B-type natriuretic peptide in heart failure.
Moe GW
Curr Opin Cardiol; 2006 May; 21(3):208-14. PubMed ID: 16601459
[TBL] [Abstract][Full Text] [Related]
3. [Natriuretic peptides in heart failure].
Emdin M; Poletti R; Giannoni A; Mazzei MG; Mammini C; Gabutti A; Agazio A; Caprioli R; Passino C
G Ital Nefrol; 2006; 23 Suppl 34():S32-7. PubMed ID: 16633992
[TBL] [Abstract][Full Text] [Related]
4. Biomarker-guided therapy in chronic heart failure: a meta-analysis of randomized controlled trials.
Felker GM; Hasselblad V; Hernandez AF; O'Connor CM
Am Heart J; 2009 Sep; 158(3):422-30. PubMed ID: 19699866
[TBL] [Abstract][Full Text] [Related]
5. Natriuretic peptides in the diagnosis and management of acute heart failure.
Mohammed AA; Januzzi JL
Heart Fail Clin; 2009 Oct; 5(4):489-500. PubMed ID: 19631174
[TBL] [Abstract][Full Text] [Related]
6. The acute effect of Metoprolol upon NT-proBNP level in patients with congestive heart failure.
Zdrenghea D; Pop D; Ilea M; Bodisz G; Mălai A; Zdrenghea M
Rom J Intern Med; 2009; 47(1):35-40. PubMed ID: 19886067
[TBL] [Abstract][Full Text] [Related]
7. Natriuretic peptides enhance the production of adiponectin in human adipocytes and in patients with chronic heart failure.
Tsukamoto O; Fujita M; Kato M; Yamazaki S; Asano Y; Ogai A; Okazaki H; Asai M; Nagamachi Y; Maeda N; Shintani Y; Minamino T; Asakura M; Kishimoto I; Funahashi T; Tomoike H; Kitakaze M
J Am Coll Cardiol; 2009 Jun; 53(22):2070-7. PubMed ID: 19477358
[TBL] [Abstract][Full Text] [Related]
8. Biomarker-guided treatment of congestive heart failure.
Xue Y; Chan J; Sakariya S; Maisel A
Congest Heart Fail; 2010 Jul; 16 Suppl 1():S62-7. PubMed ID: 20653714
[TBL] [Abstract][Full Text] [Related]
9. Natriuretic peptide testing in clinical medicine.
Rehman SU; Januzzi JL
Cardiol Rev; 2008; 16(5):240-9. PubMed ID: 18708825
[TBL] [Abstract][Full Text] [Related]
10. Role for precursor Pro-B type natriuretic peptide in assessing response to therapy and prognosis in patients with decompensated heart failure treated with nesiritide.
Miller WL; Burnett JC; Hartman KA; Hodge DO; Giuliani I; Minard F; Larue C; Jaffe AS
Clin Chim Acta; 2009 Aug; 406(1-2):119-23. PubMed ID: 19523938
[TBL] [Abstract][Full Text] [Related]
11. [Natriuretic peptides in clinical practice].
Urek R; Cubrilo-Turek M
Acta Med Croatica; 2008 Feb; 62(1):53-6. PubMed ID: 18365500
[TBL] [Abstract][Full Text] [Related]
12. Role of natriuretic peptides in heart failure patients with special reference to those on cardiac resynchronization therapy.
Ricciardi G; Pieragnoli P; Colella A; Giaccardi M; Padeletti L; Abbate R; Gensini GF; Michelucci A
Minerva Cardioangiol; 2006 Dec; 54(6):743-52. PubMed ID: 17167386
[TBL] [Abstract][Full Text] [Related]
13. The role of b-type natriuretic peptide in heart failure management.
Newton PJ; Betihavas V; Macdonald P
Aust Crit Care; 2009 Aug; 22(3):117-23. PubMed ID: 19589695
[TBL] [Abstract][Full Text] [Related]
14. Evolution of amino-terminal pro-B type natriuretic peptide testing in heart failure.
Januzzi JL; Bayes-Genis A
Drug News Perspect; 2009 Jun; 22(5):267-73. PubMed ID: 19609464
[TBL] [Abstract][Full Text] [Related]
15. Natriuretic peptides and heart failure in the patient with chronic kidney disease: a review of current evidence.
Dhar S; Pressman GS; Subramanian S; Kaul S; Gollamudi S; Bloom EJ; Figueredo VM
Postgrad Med J; 2009 Jun; 85(1004):299-302. PubMed ID: 19528304
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular and metabolic effects of natriuretic peptides.
Moro C; Berlan M
Fundam Clin Pharmacol; 2006 Feb; 20(1):41-9. PubMed ID: 16448393
[TBL] [Abstract][Full Text] [Related]
17. Natriuretic peptides and troponins in pulmonary embolism: a meta-analysis.
Lega JC; Lacasse Y; Lakhal L; Provencher S
Thorax; 2009 Oct; 64(10):869-75. PubMed ID: 19525265
[TBL] [Abstract][Full Text] [Related]
18. Natriuretic peptide-guided management of patients with heart failure: a decade of progress but still a controversy.
Baibars M; Ibrahim A; Fang JC; Sipahi I
Future Cardiol; 2010 Nov; 6(6):743-7. PubMed ID: 21142628
[No Abstract] [Full Text] [Related]
19. Natriuretic peptides and other biomarkers in chronic heart failure: from BNP, NT-proBNP, and MR-proANP to routine biochemical markers.
Lainscak M; von Haehling S; Anker SD
Int J Cardiol; 2009 Mar; 132(3):303-11. PubMed ID: 19144431
[TBL] [Abstract][Full Text] [Related]
20. Natriuretic peptide testing for heart failure therapy guidance in the inpatient and outpatient setting.
Green SM; Green JA; Januzzi JL
Am J Ther; 2009; 16(2):171-7. PubMed ID: 19300043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
